Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostate cancer schemes for androgen escape.

Literature DB >> 10835672

Prostate cancer schemes for androgen escape.

A O Brinkmann, J Trapman.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2000 PMID： 10835672 DOI： 10.1038/76194

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.

Authors: Leonard C Shank; Joshua B Kelley; Daniel Gioeli; Chun-Song Yang; Adam Spencer; Lizabeth A Allison; Bryce M Paschal
Journal: J Biol Chem Date: 2008-02-12 Impact factor: 5.157

2. Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer.

Authors: Sayuri Takahashi; Tomoyuki Watanabe; Maiko Okada; Kazuki Inoue; Takashi Ueda; Ichiro Takada; Tetsuro Watabe; Yoko Yamamoto; Toru Fukuda; Takashi Nakamura; Chihiro Akimoto; Tetsuya Fujimura; Maiko Hoshino; Yuuki Imai; Daniel Metzger; Kohei Miyazono; Yasuhiro Minami; Pierre Chambon; Tadaichi Kitamura; Takahiro Matsumoto; Shigeaki Kato
Journal: Proc Natl Acad Sci U S A Date: 2011-03-07 Impact factor: 11.205

3. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.

Authors: Seung-Jin Kim; Hojung Choi; Sung-Soo Park; Chawnshang Chang; Eungseok Kim
Journal: Mol Cells Date: 2011-02-10 Impact factor: 5.034

4. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.

Authors: Wiebke Hessenkemper; Julia Roediger; Sophie Bartsch; Adriaan B Houtsmuller; Martin E van Royen; Iver Petersen; Marc-Oliver Grimm; Aria Baniahmad
Journal: Mol Endocrinol Date: 2014-09-09

5. Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.

Authors: Thomas Nelius; Tobias Klatte; Werner de Riese; Stephanie Filleur
Journal: Int Urol Nephrol Date: 2007-06-30 Impact factor: 2.370

6. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.

Authors: D A Dart; G N Brooke; A Sita-Lumsden; J Waxman; C L Bevan
Journal: Oncogene Date: 2011-12-19 Impact factor: 9.867

Prostate cancer schemes for androgen escape.

1. Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.

2. Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer.

3. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.

4. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.

5. Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.

6. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.

7. A molecular analysis provides novel insights into androgen receptor signalling in breast cancer.

8. The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.

9. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Review 10. Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.